[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Simulations Plus Reports Profitability Rebound Ahead of Altaris Acquisition Close

Simulations Plus Inc (SLP) reports earnings on July 13, 2026, with the stock trading at $18.24 and analysts projecting full-year EPS of $0.80. The central question: can this pharmaceutical software and consulting firm stabilize earnings after a volatile year marked by sharp estimate revisions and mixed quarterly results? With analyst sentiment deteriorating sharply over the past month and the options market pricing a modest 3.96% move, investors face a critical test of whether SLP's biosimulation platform can deliver consistent growth.

Simulations Plus Inc develops pharmaceutical simulation software and provides consulting services that help drug developers predict clinical trial outcomes, optimize formulations, and accelerate regulatory approvals....

Fundamentals

See More
  • Market Capitalization, $K 368,539
  • Shares Outstanding, K 20,205
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ -67 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.30
  • Price/Sales 4.68
  • Price/Cash Flow 12.81
  • Price/Book 2.76

Options Overview Details

View History
  • Implied Volatility 54.95% (+16.50%)
  • Historical Volatility 47.55%
  • IV Percentile 7%
  • IV Rank 27.00%
  • IV High 149.14% on 01/30/26
  • IV Low 20.10% on 06/16/26
  • Expected Move (DTE 5) 0.72 (3.96%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 88
  • Volume Avg (30-Day) 196
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 2,611
  • Open Int (30-Day) 1,232
  • Expected Range 17.52 to 18.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.10
  • Growth Rate Est. (year over year) +998,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.67 +16.40%
on 06/11/26
18.68 -2.36%
on 06/30/26
+2.30 (+14.43%)
since 06/10/26
3-Month
12.60 +44.82%
on 04/13/26
18.68 -2.36%
on 06/30/26
+5.20 (+39.88%)
since 04/10/26
52-Week
11.09 +64.47%
on 03/30/26
21.01 -13.18%
on 01/23/26
+0.67 (+3.81%)
since 07/10/25

Most Recent Stories

More News
Simulations Plus Reports Profitability Rebound Ahead of Altaris Acquisition Close

Barchart Research What to Expect from SLP Earnings SLP Generated July 10, 2026 Current Price $18.24 Consensus Rating Hold Average Move 10.96% Simulations Plus Reports Profitability Rebound Ahead of Altaris...

SLP : 18.24 (-0.55%)
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN

NEW YORK , July 10, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

HUN : 11.13 (+2.96%)
OLN : 20.68 (+2.43%)
PULM : 1.7200 (-4.44%)
SLP : 18.24 (-0.55%)
Simulations Plus: Fiscal Q3 Earnings Snapshot

Simulations Plus: Fiscal Q3 Earnings Snapshot

SLP : 18.24 (-0.55%)
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported...

SLP : 18.24 (-0.55%)
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures

SAN DIEGO , July 6, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable...

SLP : 18.24 (-0.55%)
Are ACA, SLP, ALOT, FTHM Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

FTHM : 0.9531 (-4.69%)
SLP : 18.24 (-0.55%)
ALOT : 28.52 (+0.07%)
ACA : 145.00 (+0.02%)
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

SAN DIEGO , July 1, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP). The investigation...

SLP : 18.24 (-0.55%)
Are ACA, LPRO, SLP, ALOT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

LPRO : 3.12 (-0.32%)
SLP : 18.24 (-0.55%)
ALOT : 28.52 (+0.07%)
ACA : 145.00 (+0.02%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLP, FSEA, EQH, and CRBG

NEW YORK , June 24, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

SLP : 18.24 (-0.55%)
FSEA : 16.85 (unch)
CRBG : 30.55 (+0.83%)
EQH : 47.00 (+0.66%)
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP). The investigation concerns whether Simulations...

SLP : 18.24 (-0.55%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 18.53
2nd Resistance Point 18.47
1st Resistance Point 18.35
Last Price 18.24
1st Support Level 18.17
2nd Support Level 18.11
3rd Support Level 17.99

See More

52-Week High 21.01
Last Price 18.24
Fibonacci 61.8% 17.22
Fibonacci 50% 16.05
Fibonacci 38.2% 14.88
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.